Algia Pharma Gains FDA Support to Advance Novel Non-Opioid Pain Treatment Toward a Phase 2 Clinical Trial After IND-Enabling Studies With Indication Expanded to All Mild-to-Moderate Acute Pain
Algia Pharma’s novel multimodal pain regimen, AlgiaPak®, designed to deliver opioid-level pain relief without addiction risk Positive feedback from FDA suggests... Read more.
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
Substantially All Net Proceeds Expected to Be Used to Repurchase Common Stock and for Capped Call Transactions PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS... Read more.
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026 FORT MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics,... Read more.
Aviceda Therapeutics Announces Phase 2b SIGLEC Results for AVD-104 in Geographic Atrophy
SIGLEC Phase 2b data support AVD-104 as a potential therapy to reduce GA lesion growth, preserve and improve visual acuity, and reduce conversion to neovascular... Read more.
Visa Unveils New Global Stablecoins Advisory Practice
Visa Consulting & Analytics combines advanced payments strategy and expert crypto knowledge to help clients innovate and grow with stablecoins technology SAN... Read more.
Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
Registrational trial met primary endpoint, with varegacestat significantly improving progression-free survival vs. placebo (hazard ratio = 0.16, p<0.0001) Trial... Read more.
TITAN Recognized on the 2025 CDP A List
Ranks again among CDP’s global leaders for climate and water BRUSSELS–(BUSINESS WIRE)–TITAN (Brussels:TITC) has strengthened its position among the... Read more.
Pharmanovia Announces Launch of Korjuny (Catumaxomab) in Germany, a First-in-class Treatment for Malignant Ascites
Catumaxomab Is the Only Approved Drug Therapy for Malignant Ascites, a Rare and Debilitating Complication of Advanced-stage Cancer Launch Offers Prolonged Puncture-free... Read more.
Knife River Expands in Texas with Acquisition of Construction Materials Operations
BISMARCK, N.D.–(BUSINESS WIRE)–Knife River Corporation (NYSE: KNF) announced today that it has acquired the assets of Texcrete Operations LLC and TexAgg... Read more.
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion
NEW YORK–(BUSINESS WIRE)–SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty... Read more.